The aim of this study was to compare fecal microbiome, plasma, fecal and urine metabolomes, and serum biochemistry of adult companion dogs according to body condition scores. Blood, serum/plasma, urine, and fecal samples were collected from 66 clinically healthy, adult companion dogs of either normal weight (NW), overweight (OW), or obese dogs (OB). analyses included fecal microbiome analyses via 16S ribosomal RNA gene amplicon; sequencing, nontargeted plasma, fecal, and urine metabolomics using liquid chromatography/gas chromatography-mass; spectrometry, and serum biochemistry for each dog. Few significant differences in serum biochemistry and fecal microbiome Operational Taxonomic Unit (OTU) were found between weight groups and there was high OTU variation between individual dogs. NW dogs had higher relative abundance of the genus Eubacterium (log-fold change 4.3, adjusted P value = .003) and lower relative abundance of the family Bifidobacteriaceae (log-fold change ¡3.6, adjusted P value = .02) compared to OB dogs. The microbiome of NW dogs had higher OTU richness compared with OB dogs. Metabolome analysis showed 185 plasma, 37 fecal, and 45 urine metabolites that significantly differed between NW and OW or OB dogs. There were notable significant differences in relative abundance of several plasma phospholipid moieties and fecal volatile fatty acids between weight phenotypes. The combinations of host and gut microbiota and metabolic shifts suggest a pattern that could help detection of early metabolic changes in overweight dogs before the development of obesity related disease. The results of this study support the need for continued investigation into sensitive measures of metabolic aberrancies in overweight dogs.
Introduction
Obesity is a multifactorial nutritional disorder, 1 highly prevalent in dogs in developed countries. [2] [3] [4] Overweight (OW) and obese (OB) dogs suffer from decreased quality of life, shorter life expectancy, and are at greater risk for multiple diseases including osteoarthritis, dyslipidemia, cardiovascular disease, and cancer. 5, 6 Obesity is readily diagnosed on physical examination, where excess body fat can be estimated with body condition scores (BCS), or measured by bioimpedance spectroscopy, deuterium water, or dual energy X-ray absorptiometry scans. [7] [8] [9] Some animals may be at higher risk to develop a metabolic, obesity-related, secondary disease than others; however, identifying the overweight animals with increased risk is a challenge. The detection of abnormal clinical parameters has had limited success in early identification of developing weight related comorbidities. Elevated white blood cell counts, blood glucose, blood urea nitrogen, creatinine, phosphorus, calcium, cholesterol, and alkaline phosphatase have been reported in overweight dogs, but these appear to be inconsistent findings and have low specificity to obesity-related diseases. [10] [11] [12] [13] [14] [15] High throughput techniques such as metabolomics and microbiome analysis have shown promise for evaluating altered metabolic states in people. [16] [17] [18] The identification of metabolic patterns/profiles associated with early detection of obesity may become useful to disease prevention of diabetes, renal disease, liver disease, and even cancer. For example, patterns of metabolic shifts, altered fecal volatile organic compounds and fecal microbiota were reported in human obesity-related fatty liver disease as means of early and noninvasive detection. 16 The role for the gut microbiome in obesity is suggested to be related to enhanced capacity to harvest energy from food, 19 particularly via fermentation and increased carbohydrate bioavailability. In people, obesity-related differences exist in abundance of Clostridium spp., Faecalibacterium prausnitzii, Bifidobacteria, Eubacterium, Bacteroides, Lactobacilli, and Prevotellacea. [20] [21] [22] [23] [24] However, only few studies evaluated differences in the fecal microflora composition between normal weight (NW) and OW dogs. 25, 26 Metabolomics is the study of all detectable small molecules in a biological sample, and can provide information on subclinical metabolic alterations that are associated with disease outcomes. 27 Metabolome analysis has revealed previously unknown alterations in amino acid, lipid, and carbohydrate metabolism across species with underlying links to obesity, inflammation, oxidative stress, and perturbations in the gut microflora. [28] [29] [30] [31] [32] Several studies showed potential relationships between stool metabolites and certain bacterial species providing further insight into microbial functions and the association between gut microflora, health, and disease. 16, 33, 34 The plasma, fecal, and urine metabolomes of overweight/obese humans were shown to have altered volatile organic compounds, 16 plasma lipid metabolism, [35] [36] [37] and amino acid metabolism 36, 37 that reflects shifts in energy metabolism pathways. The objective of this study was to determine differences in fecal microbiome composition plasma, fecal, and urine metabolites, and serum biochemical analytes in companion dogs according to weight phenotype. We hypothesized that there will be differences in fecal microbiome composition and diversity and the plasma, fecal, and urine metabolome would show altered lipid, amino acid, and purine metabolic pathways when compared with NW dogs. Also, OW and OB dogs were hypothesized to have a higher number of serum biochemical values that are outside of established normal ranges.
Materials and Methods
Study participants were clinically healthy adult dogs recruited for future participation in 1 of 3 previously reported clinical trials. [38] [39] [40] All samples collected and analyzed for this report were acquired from companion dogs at enrollment/baseline and they had not received any intervention or manipulation prior to sampling. Dogs were enrolled at the Colorado State University Veterinary Teaching Hospital (Fort Collins) and the Wellington Veterinary Hospital (Wellington). IACUC approved clinical trial operations, etc, and the informed, written consent obtained from all owners. A single veterinarian determined that all enrolled dogs were healthy (aside of obesity status) according to the provided medical history and physical examination. In addition, a complete serum biochemistry panel and a complete blood count (CBC) with differential count were conducted for each participant. All dogs enrolled were free of clinical evidence for metabolic disease according to the results of these standard tests. A BCS was assigned to each dog on a 9-point scale 7 where a score of 4 or 5 is considered "ideal" and every unit increase in BCS over 5 corresponds to an approximate 10% increase in bodyweight, such that a BCS of 8/9 corresponds to approximately 30% excess bodyweight. 8 Dogs were divided into weight groups based on BCS:
dogs with a BCS of 4-5 were considered "normal weight" (NW), dogs with a BCS of 6-7/9 were considered "overweight" (OW), and dogs with a BCS 8-9/9 were considered "obese" (OB). 8 Underweight dogs were not included in the study. Signalment data (breed, age, and sex) for each dog was collected from the owner and medical records (Table 1) .
Serum Biochemistry and Complete Blood Cell Counts
Blood was collected via venipuncture into a serum separation tube without anticoagulant for 15 minutes and serum was collected following centrifugation for 15 minutes at 1500 £ g. Blood for analysis was collected into tubes containing EDTA and stored at 4°C for up to 4 hours until analysis. All clinical analyses were performed at the Clinical Pathology Laboratory at Colorado State University as previously described. 39 Briefly, serum biochemistry was performed under standard conditions on a clinical chemistry analyzer (Hitachi 917, Roche Diagnostics; Indianapolis, IN) and the CBC was performed on an automated analyzer (Advia 120, Bayer; Tarrytown, NY).
Canine Fecal Microbiome Analysis
Owners were instructed to collect fresh fecal samples (samples accepted were within 5 hours of being voided). Fecal samples were immediately frozen after collection and stored at ¡20°C, lyophilized until dry, and stored at ¡80°C until extracted for microbial analysis. In brief, DNA was extracted from 150 mg of lyophilized stool using an isolation kit (MO BIO PowerFecal DNA Isolation Kit, MO BIO Laboratories, Carlsbad, CA) per the manufacturer's instructions. The targeted 16S small-subunit ribosomal genes at region V4 were amplified using universal 515F (5 0 -GTGCCAGCMGCCGCGGTAA-3 0 ) and 806R GGAC-TACVSGGGTATCTAAT primers 41 via PCR using a 12 bp unique Golay barcoded primer for each sample. 42 The sample amplicons were subsequently cleaned using cleaning kits (MO BIO UltraClean-htp 96 Well PCR Clean-Up Kits, MO BIO Laboratories, Carlsbad, CA), quantified (Quant-iT PicoGreen dsDNA Reagent and Kits, Life Technologies Corporation, Grand Island, NY), and pooled for sequencing. DNA extraction, amplification, and cleaning were performed at the Natural Resource Ecology Laboratory at Colorado State University. Sequencing of 2 £ 250 cycles was performed on a MiSeq platform (Illumina, San Diego, CA) at the Research Technology Support Facility Genomics Core at Michigan State University. Sequencing data were processed using the Quantitative Insights into Microbial Ecology (QIIME 1.7.0) pipeline 43 for determining operational taxonomic unit (OTU), taxonomy assignment, and UniFrac analyses. 44, 45 Two reads were performed on each sample.
Sequence data were demultiplexed and filtered for quality using the QIIME pipeline default settings and chimera sequences were removed. 43 Sequence reads were normalized using the rarefying procedure as implemented in QIIME. The level for rarefying was taken from the sample with the lowest number of reads across the entire dataset. Taxonomies were assigned to each sequence using a default confidence setting of 0.5 (RDP Classifier: http:// rdp.cme.msu.edu/index.jsp). OTUs were picked using the Data are reported as median and interquartile range. * Weight class was determined by Body Condition Score (BCS) using a 9 point scale (Laflamme, 1997) . Continuous variables (age and weight) were evaluated for differences across groups using a KruskalÀWallis test and categorical variables (sex) were evaluated using a chi-square test. P < .05 was considered significant. Groups with significant differences are indicated with different letter superscripts.
y Age as reported by owner. z All dogs were neutered with the exception of 1 male in the normal weight group, and 1 female in each of the overweight and obese groups.
pick_open_reference_otus.py command, with default settings. The resulting OTU matrix contained OTUs as rows, sample numbers as columns, and counts of hits as matrix cells. This matrix was imported into a computer software for descriptive and inferential analyses (R version 3.2.3, R-Core Team, Vienna, Austria). 46 OTUs present in fewer than 5 samples were removed from further analyses to avoid nonrobust estimates due to sparseness. Remaining OTU counts were normalized using cumulative sum scaling as implemented in metagenomeSeq; 47 this method accounts for uneven sequencing depth while avoiding bias that can be introduced with the rarefying procedure. 48 A default value of 0.5 % was used for the procedure. In order to perform a taxonomy-based analysis (in addition to an OTU-based analysis), OTUs were matched to a reference taxonomy and the taxa summaries were created with standard QIIME workflows with gg_otus97 as the reference set. Normalized OTU counts were aggregated to various taxonomic levels (species through phylum) using the "aggTax" function in metagenomSeq. 47 The raw data files were uploaded to National Institute of Health, Bioproject Database (http://www. ncbi.nlm.nih.gov/bioproject/417964). The fecal microbiome richness and diversity and the relative abundance of the fecal microbiome composition are presented in Supplementary Tables 1 and  2 , respectively.
Nontargeted Metabolomics Using Gas Chromatography and Liquid ChromatographyÀMass Spectrometry
Plasma, fecal, and urine samples available from each dog were prepared, extracted and derivatized as previously described. 49 Briefly, lyophilized fecal samples were ground to a powder using a mortar and pestle, and metabolites were extracted by adding 1 mL of ice cold methanol: water (80:20, v:v) to 100 mg of feces and incubated for 1 hour at ¡80°C. Samples were then centrifuged at 1500 £ g for 5 minutes at 4°C and 800 mL of the extract was transferred into 1 mL 96 well plates. For plasma and urine, 150 mL and 400 mL of each sample was transferred to micro well plates, respectively. For gas chromatography (GC)-mass spectrometry (MS) analysis, extracts were dried in a speedvac (Thermo Fischer Scientific Inc., Waltham, MA) and methoximated by resuspending in pyridine (50 mL) with 25 mg/mL of methoxyamine hydrochloride and incubated at 60°C for 45 minutes twice, with 10 minutes sonication in between. After methoximation, samples were incubated with 50 mL of N-methyl-N-trimethylsilyltrifluoroacetamide with 1 % trimethylchlorosilane (MSTFA + 1% TMCS, Thermo Fischer Scientific Inc., Waltham, MA) at 60°C for 30 minutes, followed by centrifugation at 3000 relative centrifugal force for 5 minutes. Samples were then cooled to room temperature (»22°C), and the supernatant (80 mL) was transferred to a 150 mL glass insert in a GCÀMS autosampler vial. For liquid chromatography (LC) analysis, 100 mL of each sample was centrifuged at 13,000 relative centrifugal force at 4°C. The supernatant was transferred to an autosampler vial and directly injected. GC and LCÀMS run conditions were as previously described. 49 Individual features, described by mass, charge, and retention time were generated in a cloud-based metabolomic data processing platform (XCMS Online: https://xcmsonline. scripps.edu/landing_page.php?pgcontent=mainPage). 50 The mean abundance of duplicate injections was normalized to total ion current and clustered together into individual metabolites using the RAMClust deconvolution algorithm. 51 The relative abundance of each cluster was calculated based on the weighted sum of all features within the cluster and scaled to a median of one. Spectra were annotated based on mass spectral and retention time/index matching against in-house and external libraries (NIST v12: www.nist.gov; Massbank: http://www.massbank.jp/? lang=en; Metlin: https://metlin.scripps.edu/landing_page.php?pgcon tent=mainPage; Golm: http://gmd.mpimp-golm.mpg.de metabolite databases). For this study, each annotated metabolite was reported with an experimental library identification number "C" for compound number, identification confidence, 52 and structural and database ID numbers. Supplementary Table 3 shows the relative abundance of metabolites that were significantly different between weight groups and Supplementary Table 4 lists the GC and LC mass spectral library used in this study and each metabolite is referenced by its library/cluster number.
Statistical Analysis
Baseline characteristics of the dogs were evaluated using a KruskalÀWallis test for the continuous variables of age and weight, followed by Dunn's Multiple Comparison test to determine differences between specific groups (NW vs. OW, NW vs. OB, and OW vs. OB). A chi-square test was used to evaluate groups for differences in the categorical variables of sex and presence of abnormal clinical blood values (outside the normal ranges established by the Colorado State University Diagnostic Laboratory for dogs; where all outcomes were dichotomous and recoded as yes or no for whether the value was abnormal or not). All parameters evaluated had expected values greater than 1 and at least 20% of the expected values were greater than 5 to meet the assumptions for the chi-square test. Parameters not meeting these assumptions are noted in Supplementary Table 1 and Supplementary Fig 1. Differences in proportional data were considered significant when P < .05, and trends were considered present when P < .10. Statistical analyses were performed via computer software (GraphPad Prism, Version 5.03, San Diego, CA).
Calculations performed on clinical blood parameters were analyzed with an ANCOVA where both weight group and age were evaluated. Pair-wise comparisons were performed with TukeyÀKramer and parameters without normal distributions were log transformed for statistical evaluation. The raw values, not the transformed values are reported for all parameters.
The fecal microbiome data were analyzed using generalized linear models of normalized counts to test for differences in richness and Shannon's diversity between NW, OW, and OB dogs. The influence of age on richness and diversity was evaluated using a chi-Square likelihood ratio test of models with and without age as a covariate. When age was found to exert a significant effect on model fit, it was included in the final multivariable model as a confounder. Comparisons of richness and diversity were made at each taxonomic level, as well as across all OTUs. Zero-inflated Gaussian mixture models were used to model abundance of zero-inflated and over dispersed microbiome counts at each taxonomic level and across all OTUs, 47 and pairwise comparisons of abundance (measured as log-fold change) between NW, OW, and OB dogs were assessed using limma, 53 with a critical a of 0.05 for BenjaminiÀHochberg adjusted P values to account for multiple comparisons. We were not able to include age as a covariate in these models due to low degrees of freedom. Overall microbiome composition was compared between NW, OW, and OB dogs using nonmetric multidimensional scaling ordination of Euclidean distances between Hellinger-transformed normalized counts, specifying use of 2 dimensions. 54 The nonmetric multidimensional scaling stress value, as well as the analysis of similarities R-statistic and corresponding P value were all used to evaluate the significance of the ordination by body weight classification (NW, OW, or OB). The relative abundance of each plasma, fecal, and urine metabolite was scaled to a median value of 1 and is presented as the median and interquartile range. To determine differences in the relative abundance of each cluster/metabolite between dogs in each group (NW, OW, OB), a mixed model ANOVA was used. Age was evaluated using the distribution pattern of P values for age for each metabolite. The distribution was found to be random (data not shown) indicating no effect of age; therefore, age was not accounted for in the metabolomics model.
Results

Characteristics of Canine Participants
Baseline samples from 66 adult NW (n = 17), OW (n = 27), and OB (n = 22) dogs, enrolled in 3 different dietary intervention studies [38] [39] [40] were used in this study. The median age in years as reported by owners was 3.0 (2.5-4.5) in NW dogs, 5.0 (3.0-6.0) in OW dogs, and 5.5 (3.0-7.0) in the OB group (Table 1) . There was a significant difference in age across the 3 weight groups (P = .04) with the median age of the NW dogs lower than the OB dogs (P < .05). This was found to affect the statistical evaluation of serum biochemistry analytes and fecal microbiome richness and diversity and was included in the statistical evaluation of these parameters. The median weight of the NW dogs was 22.5 kg (19.4-30.8 kg), 30.6 kg (22.4-37.3 kg) for the OW dogs, and 37.7 (24.6-39.8 kg) for the OB dogs (Table 1) . Dogs in the OB group were significantly heavier than dogs in the NW group (Table  1 ; P < .05). However, when the estimated ideal weights of each dog according to BCS were calculated to account for size differences, there was no difference between groups (data not shown). There were no differences in the distribution of sexes between the groups ( Table 1 ). The range of breeds represented in this study included: Labrador Retrievers, n = 8; Labrador cross, n = 6; Australian Cattle Dogs, n = 5; Terriers (American Pit Bull and Boston), n = 5; Border Collie, n = 1; Border Collie cross, n = 4; Golden Retriever, n = 4; Australian Shepherd, n = 3; Australian Shepherd cross, n = 1; Hounds (Daschund and Basset), n = 3; Dalmatian, n = 2; Saint Bernard, n = 2; Spaniels, n = 2; Boxer, n = 1; Corgi, n = 1; Karelian Bear Dog cross, n = 1, Keeshond, n = 1, Rottweiler, n = 1; Shih Tzu, n = 1; Standard Poodle, n = 1; Wirehair Pointer, n = 1; and otherwise unknown mixed breeds, n = 12. All dogs were fed commercial maintenance diets at the time of the study.
CBC and biochemical analysis was completed in 66 dogs (NW, n = 17; OW, n = 27; OB, n = 22). Due to insufficient or missing samples, not all analyses were completed for every dog. Plasma metabolomics was performed in 59 dogs (NW, n = 13; OW, n = 25; OB, n = 21), fecal metabolomics in 64 dogs (NW, n = 17; OW, n = 25; OB, n = 22), and urine metabolomics for 51 dogs (NW, n = 17; OW, n = 22; and OB, n = 12). Fecal microbiome was analyzed from 50 dogs (NW, n = 17; OW, n = 21; and OB, n = 12).
Fecal Microbiomes of Normal Weight, Overweight, and Obese Dogs
The sequence data from the fecal microbiome analysis were clustered into 808 distinct OTUs, 454 of which were present in fewer than 5 samples and therefore removed from further analyses. The remaining 354 OTUs were assigned to 6 known phyla, which comprised 12 classes, 18 orders, 35 families, and 39 genera of bacteria. Across all samples, the majority of normalized counts belonged to the phylum Firmicutes (56.3%), followed by Bacteroidetes (38.1%). Actinobacteria, Cyanobacteria, Proteobacteria, and Verrucomicrobia together comprised 3.6% of all normalized counts, and 2.0% of normalized counts could not be assigned to a phylum. Extensive variation was present between individual dogs at the phyla level (Fig 1) . Within Firmicutes, the top 3 most abundant genera were Blautia (51.2%), Ruminococcus (17.6%), and Clostridium (9.9%). Within Bacteroidetes, normalized counts were distributed between the genera Bacteroides (50.9%) and Prevotella (49.0%). Based on nonmetric multidimensional scaling stress value, as well as the analysis of similarities R-statistic and corresponding P value, the overall microbiome composition of NW, OW, and OB dogs was not significantly different at any level (analysis of similarities R-statistic < 0.10, P > .05; Supplementary Table 1 ). The fecal microbiomes of OB and OW dogs showed a trend toward lower microbial richness and Shannon's diversity when compared to NW dogs, but this comparison did not reach statistical significance (Supplementary Table 1 ).
There were significant differences in relative abundance of specific taxa when comparing NW, OW, and OB dogs (Fig 1; Supplementary  Table 2) . At the class level, Erysipelotrichi were more abundant in OW compared to OB dogs (log-fold change 4.3, adjusted P value = .01), and this was driven by differences in the genus Eubacterium, although the difference was apparent at all levels of the taxonomy including Erysipelotrichales and Erysipelotrichaceae (order and family levels, respectively). Class Actinobacteria was more abundant in OB dogs compared to NW dogs (log-fold change ¡2.3, adjusted P value = .04). At the order level, Bifidobacteriales were less abundant in OW compared to OB dogs (log-fold change ¡3.6, adjusted P value = .02) and Aeromonadales tended to be more abundant in OW compared to OB dogs (log-fold change 3.6, adjusted P value .08). Compared to OB dogs, NW dogs also had higher relative abundance of Erysipelotrichi, Erysipelotrichales, and Erysipelotrichaceae (class, order and family levels, respectively), and we speculate that this finding was also driven by difference in the genus Eubacterium (log-fold change 4.6, adjusted P value = .002). As with OW compared to OB dogs, NW dogs also had lower levels of the order Bifidobacteriales (log-fold change ¡3.8, adjusted P value = .01). There were no significant differences of any taxa at any level when comparing normal-weight and overweight dogs (Fig 1B) .
When analyzed as OTUs, the genus Blautia was significantly more abundant in NW and OW dogs compared to OB dogs (log-fold change 3.4 and 2.2 and adjusted P value = .002 and .03, respectively), as was the family Lachnospiraceae (log-fold change 2.6 and 2.7 and adjusted P value = .02 and .03, respectively) and the species Eubacterium biforme (log-fold change 4.3 and 4.0 and adjusted P value = .003 and .004, respectively) ( Fig 1C) . The family Ruminococcus was more abundant in NW than OB dogs (log-fold change 2.3, adjusted P value = .01). OTUs within the species Prevotella copri (log-fold change 4.3, adjusted P value = .03), and the genus Clostridium (log-fold change 3.2, adjusted P value .03) were more abundant in OW than OB dogs.
Plasma, Fecal, and Urine Nontargeted Metabolome of Normal Weight, Overweight, and Obese Dogs Plasma, fecal, and urine samples were analyzed via GCÀ and LCÀMS and the relative abundance of compounds were compared between NW, OW, and OB dogs.
The relative abundance of each metabolite that significantly differed by weight class is presented in Supplementary Table 3 . Fig 2 shows the relative abundance for each metabolite that was significantly different between weight groups as a ratio between OW/NW or OB/NW.
For plasma, 30/554 (GCÀMS) and 155/348 (LCÀMS) of the identified metabolites varied between weight class (Supplementary Table 3) . A total of 1112 compounds were detected in feces by GCÀMS and 795 compounds were detected by LCÀMS. No fecal metabolites detected by GCÀMS were significantly different between the weight groups, whereas 37 fecal metabolites detected by LCÀMS showed differences according to weight phenotype. In urine, only 1 of 1139 metabolites detected by GCÀMS was different by weight group. There were 1318 urine compounds detected with LCÀMS, 44 of which were different by weight class. Of the 267 compounds detected in plasma, feces, or urine by GCÀ or LCÀMS with significant differences between weight classes, 79 were subsequently identified with database spectral matches. Metabolites that were increased in OW or OB compared to NW dogs were primarily lipids (33/42 identified metabolites) and included 18 Glycerophospholipids, 1-stearoyl-phosphatidylethenolamine, 6 Sphingolipids, 4 Sterol lipids, 3 Fatty Acyls, and 2 Glycerolipids (triglycerides; Supplementary Table 3 and Fig 2) . Five metabolites associated with protein metabolism were increased on OW or OB dogs compared to NW, including 3 amino acid derivatives and 2 peptides. There were 2 carbohydrates elevated in OW or OB dogs, glucose and glycerol; 1 cofactor-dihydrobiopterin, and 1 nucleic acid. A total of 37 metabolites were decreased in OW, and OB dogs compared with NW dogs. A total of 28 were lipids, 5 proteins, 1 phytosterol, 1 cofactor, 1 bile pigment, and 1 nucleic acid (Supplementary Table 3 ). Table 2 shows the median and range for 39 clinical serum and whole blood parameters for all 66 dogs. Aspartate aminotransferase, gamma-glutamyl transpeptidase, and chloride were significantly different between NW, OW, and OB dogs when adjusted for age. Aspartate aminotransferase was decreased by an average of 4 U/L in OB dogs compared to NW; chloride was decreased on average by 2 mmol/L; and g-Glutamyl transpeptidase was decreased in both OW and OB dogs by 3 U/L and 2.5 U/L, respectively.
Serum Biochemistry and Complete Blood Cell Counts of Normal Weight, Overweight, and Obese Dogs
The most commonly observed parameter outside of normal ranges was the albumin:globulin ratio which was elevated in 38/66 dogs; however, the distribution of dogs with elevated albumin:globulin ratios was not different by weight group (P = .962). Hemolysis of blood samples was noted in 25/66 dogs, and the distribution of sample hemolysis was different across weight group (P = .014) with OW dogs having the highest proportion of hemolytic samples (15/27), followed by OB dogs (8/22), and then NW dogs (2/17). Creatinine kinase was elevated in 9/66 dogs, all of which were OW or OB, and this Positive log fold changes indicate increased phyla abundance in NW and OW dogs compared with OB dogs. All shown differences were significant (adjusted P value < .05) except for #, which indicates a trend (adjusted P value < .10).
distribution was also different across weight group (P = .038) with OW dogs exhibiting the highest proportion (7/27), followed by OB dogs (2/22). AST was elevated in 5/66 dogs and slightly below 16.3 U/ L in one NW and one OW dog. All 5 dogs with elevated AST levels were OW (5/27), thus the proportion of abnormal values by weight group was different (P = .020). Cholesterol was elevated in 5/66 dogs and reduced in 1 OB dog, and the proportion of dogs with abnormal values tended to differ by weight group (P = .080): NW (2/17), OW (0/ 27), and OB (4/22). The fourth most frequent parameter outside of the normal range was platelet count, which was decreased in 14/66 dogs, 13 of which had clumped platelets (data not shown). The proportion of dogs with low platelets was equally distributed across weight classes: 5/17 NW, 5/27 OW, and 4/22 OB (P = .631).
Discussion
The tandem analysis of fecal microbiome, plasma, fecal and urine metabolomes, and serum biochemistry of NW, OW, and OB companion dogs was implemented in this investigation to enable identification of subclinical differences that may result from excess adiposity. The fecal microbiome was analyzed to determine distinctions that could contribute to metabolic alterations in OW or OB dogs. Consistent with previous reports, the phyla Firmicutes were the most abundantly represented, 26, 55, 56 followed by Bacteroidetes; yet, possibly due to individual variation, the fecal microbiome composition differences did not reach statistical significance by weight group. OB dogs had lower abundance of Erysipelotrichi, Erysipelotrichales, Erysipelotrichaceae, and Eubacterium, (class, order, family, and genus, respectively) at the taxonomic level, while OTU analysis also revealed lower abundance of E. biforme compared to NW and OW dogs. High levels of Eubacterium dolichum have been found to be associated with increased visceral fat mass in people; 57 whereas our results display an inverse relationship between obesity and E. biforme in dogs. Eubacterium ferment dietary nondigestible carbohydrates into short-chain fatty acids in the gut, with propionate and butyrate having important health promoting and anti-inflammatory roles on the host colonocytes. 58 One interpretation of the findings in the present study is that the decrease in Eubacterium spp. in the gut could reduce production of short-chain fatty acids that supports a higher, yet subclinical inflammatory stress that reflects decreased health status in the OB dogs. OB dogs had higher abundance of order Bifidobacteriales than NW and OW dogs, and also had higher abundance of class Actinobacteria compared to NW dogs. Within the order Bifidobacteriales, genus Bifidobacterium is implicated in preventing obesity and altering lipid metabolism in both human and rodent studies, however strain variations exist that can promote excess weight gain. 59 Previous studies reported increases in the phylum Actinobacteria (to which the family Bifidobacteriaceae belongs) in obese companion dogs. 26 Increased
Actinobacteria abundance was also demonstrated in obese humans. 60 Obese dogs had lower abundance of the genus Blautia than NW and OW dogs. Blautia are a dietary carbohydrate responsive, butyrate producing bacteria. 61 Decreases in Blautia spp. in dogs have been associated with acute diarrhea, 62 and Blautia spp. in human fecal microbiomes have been found to vary by adiposity. 63 Altered lipid and carbohydrate metabolism as well as increased adiposity may be related to microbiome shifts through several mechanisms, including interactions with the innate immune system and metabolic inflammation through toll-like receptors, gut absorption and permeability to lipopolysaccharides, and bacterial bile acid modifications. 64, 65 These results support the need for follow-up investigations into the roles for microbiome composition and metabolism changes during canine weight gain and development of obesity. Nontargeted metabolomics analysis of the plasma, feces, and urine revealed 267 compounds that varied among these weight groups, with the majority of the variation detected in the plasma. Most differences in the identified metabolites trended similarly for both the OB and the OW dogs when compared to the NW. As expected, the differences between OB and NW were larger than differences between OW and NW dogs (Fig 2) . From the list of annotated plasma metabolites, the majority included lipids such as fatty acids and phospholipids. Changes in plasma lipids in humans with increased body mass index have been previously documented, 37, 66 and further support the hypothesis that altered energy metabolism and glucose homeostasis occur in OW and OB dogs. The OW and OB dogs in the present study showed elevated plasma lysophosphatidylcholine (LysoPC) (20:4), 4 other LysoPC moieties were decreased, and several phosphatidylcholine lipids were elevated. While the association between phosphatidylcholine lipids, LysoPC, and obesity is unclear, similar findings have been documented in obese mice, humans, and pigs. 29, 30, 67 In addition, a previous study that evaluated the effects of rapid weight gain in y Data are shown as median and range (minÀmax) and were evaluated for differences across groups using an ANCOVCA with the variables of age and body weight classification and false discovery rate-corrected. Differences between groups were determined with pairwise comparisons and a TukeyÀKramer correction. P < .1 was considered significant. Groups with significantly different medians are indicated with different letters. z Parameters not normally distributed were log transformed for statistical analysis however the actual, untransformed values are reported.
beagles on the plasma metabolome showed changes in plasma phospholipids in the chronic stages of weight gain. 68 Shifts in plasma phospholipids may represent changes in lipid metabolism and/or increased b-oxidation for energy production in individuals with excess adiposity. [35] [36] [37] Plasma phospholipids may act as targets for the research and development of targeted tests to evaluate the risk of obesity related metabolic alterations in dogs. In light of this finding, consistency across species is needed since obesity related derangements in lipoprotein metabolism may be a risk for several concurrent morbidities such as hyperlipidemia and pancreatitis. 69 A previous investigation of the fecal metabolome in overweight and obese humans demonstrated alterations in volatile organic compounds and fatty acids that may be associated with altered microbiota. 16 The fecal metabolome of the obese and overweight dogs showed decreased abundance of several fatty acids including linoleic acid, ferulic acid, 1,28-dicaffeoyloctacosanediol (a coumaric acid derivative), and colnelenic acid which act as functional antioxidants as well as modulate inflammation, and reduce risk for cardiovascular disease. 70, 71 The relative decrease in these metabolites may reflect the subclinical chronic inflammation and oxidative stress associated with obesity in dogs. The observed adiposity-related differences in gut microbiome and fecal metabolome are likely interlinked, as the gut microbiota is responsible for the production of many organic compounds including fatty acids, which in turn influence the microbiota's composition and diversity. Decreased abundance of fecal vitamin D metabolites in the OW and OB dogs may be explained by shifts in the gut microbiota and changes in bile acids as a fat-soluble vitamin. 72 In turn, vitamin D was shown to have an important role in maintaining gut microbiome composition.
72,73
The present study showed lower urinary levels of 1-methylhypoxanthine in OB and OW dogs, while urinary methylxanthine abundance was increased. Similar alterations in purine metabolism have been described in overweight people where the decrease in xanthine was also associated with hyperuricemia, suggesting that the enzymatic activity of xanthine oxidase is increased in obese individuals. 74 Urine of the OB and OW dogs had increased N-acetyltryptophan, betaine, and carnosine and decreased amino acid metabolism including conjugated arginine, saccharopine, and biopterin. These changes differ from those previously described for overweight Labrador Retrievers during fasting and as postprandial response. 75 Altered amino acid metabolism was documented in humans, rats, and mice suffering from type-2 diabetes. 76 Adiposity-related insulin resistance, resulting in gluconeogenesis and perturbation in energy metabolism and eventually increased amino acid oxidation may in part explain the decreased urinary amino acids and their metabolites. Increased urinary excretion of carnosine and betaine, which are compounds that act as an antioxidant and as a methyl donor, respectively, may reflect a subclinical metabolic stress from increased adiposity.
Since carnosine is present in high concentrations in muscle tissues, the increased urinary abundance of this compound may also reflect increased muscle catabolism. Clinical blood parameters, such as g-Glutamyl transpeptidase, and chloride were reduced in OW and OB dogs (Table 2 ), yet their values were within normal ranges. g-Glutamyl transpeptidase increase was previously described in obese dogs compared with nonobese dogs. 15 g-Glutamyl transpeptidase may become elevated as a result of changes in the biliary system or cholestasis; 77 therefore this finding suggests differences in bile composition or metabolism in overweight dogs. In this cohort, the level of hemolysis was not associated with obesity; however more OW and OB dogs had hemolytic blood samples than NW dogs, and could also represent a true phenomenon in which dogs with excess adiposity could have friable red blood cell membranes from the alterations in lipids, and thus a higher probability of red cell lysis. Erythrocyte membranes from overweight and obese humans have been shown to have altered lipid profiles and decreased membrane fluidity; 78 therefore, further investigation into erythrocyte membrane integrity is warranted in OW and OB dogs. An alternative explanation to the increase in hemolysis may be that venipuncture might have been technically more difficult from the subcutaneous fat in OW and OB dogs. A previous retrospective analysis of hematological and biochemical parameters of OB and OW dogs showed higher leukocyte count; higher plasma protein and globulin; higher sodium, calcium, and anion gap; and lower chloride compared with NW dogs.
14 A possible explanation to the reduced chloride in OW and OB dogs would be metabolic alkalosis, which may result from metabolic disturbances and increased loss of chloride in the gastrointestinal tract. 79 Several study limitations should be considered such as the relationship between age and weight phenotype, whereby excess bodyweight was positively correlated with age, although no dogs had evidence of age related morbidities. This limitation may be more pronounced when using client-owned dogs rather than colony dogs because obesity has higher prevalence in middle-aged dogs. 4 In addiiton, this study limitation also impacts interpretation due to age effects on the microbiome and metabolome. 80 Similarly, the dogs in the study were of different breeds, neuter status, activity level, and diet. These variables are all challenging to balance between the weight groups, and future studies should stratify these parameters with a larger number of dogs and weight groups. Another limitation of metabolomics is the use of existing databases that include primarily humans and rodent metabolite identifications which may differ from those in canines. Finally, the inherent variability noted in the fecal microbiome of companion dogs suggests that larger numbers of dogs are needed to characterize microbiome shifts that occur in overweight and obese dogs.
Conclusion
The evaluation of fecal microbiome, plasma, fecal and urine metabolomes, and serum biochemistry provided an integrative assessment of the metabolic alterations that occur as a result of weight gain and obesity. Our preliminary investigation provided compelling evidence that microbiome analysis combined with metabolomics merits further study to improve the understanding of the impact of obesity on metabolism and health. The plasma metabolites were identified from this study to show the greatest differentiation according to obesity status when compared to minor changes found in hematological parameters, serum biochemistry, fecal microbiota, and the fecal and urinary metabolomes. Further investigation of the plasma phospholipid moieties in OW canine patients is warranted for metabolic shifts to be considered candidate biomarkers of canine obesity related comorbidities and disease risk.
